Trading of Wellgistics Health was halted at 09:41 AM ET due to "LULD Pause" and resumed at 09:46 AM ET.

Wellgistics Health (MEDS) Competitors

Wellgistics Health logo
$1.34 +0.61 (+84.14%)
As of 03:59 PM Eastern

MEDS vs. RDGT, HKPD, MCK, COR, and CAH

Should you buy Wellgistics Health stock or one of its competitors? Wellgistics Health's main competitors and comparable companies include Ridgetech (RDGT), Hong Kong Pharma Digital Technology (HKPD), McKesson (MCK), Cencora (COR), and Cardinal Health (CAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare distributors" industry.

How does Wellgistics Health compare to Ridgetech?

Ridgetech (NASDAQ:RDGT) and Wellgistics Health (NASDAQ:MEDS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, media sentiment, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

Ridgetech has a net margin of 0.00% compared to Wellgistics Health's net margin of -564.70%.

Company Net Margins Return on Equity Return on Assets
RidgetechN/A N/A N/A
Wellgistics Health -564.70%N/A -105.00%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ridgetech
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Wellgistics Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

45.3% of Ridgetech shares are owned by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are owned by institutional investors. 22.6% of Ridgetech shares are owned by insiders. Comparatively, 19.5% of Wellgistics Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Ridgetech has a beta of -0.17, meaning that its share price is 117% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -3.14, meaning that its share price is 414% less volatile than the broader market.

Ridgetech has higher revenue and earnings than Wellgistics Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Ridgetech$132.16M0.03-$1.25MN/AN/A
Wellgistics Health$23.34M0.10-$101.28M-$20.41N/A

In the previous week, Wellgistics Health had 1 more articles in the media than Ridgetech. MarketBeat recorded 1 mentions for Wellgistics Health and 0 mentions for Ridgetech. Wellgistics Health's average media sentiment score of 1.08 beat Ridgetech's score of 0.00 indicating that Wellgistics Health is being referred to more favorably in the news media.

Company Overall Sentiment
Ridgetech Neutral
Wellgistics Health Positive

Summary

Ridgetech beats Wellgistics Health on 7 of the 10 factors compared between the two stocks.

How does Wellgistics Health compare to Hong Kong Pharma Digital Technology?

Wellgistics Health (NASDAQ:MEDS) and Hong Kong Pharma Digital Technology (NASDAQ:HKPD) are both small-cap healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

Hong Kong Pharma Digital Technology has a net margin of 0.00% compared to Wellgistics Health's net margin of -564.70%.

Company Net Margins Return on Equity Return on Assets
Wellgistics Health-564.70% N/A -105.00%
Hong Kong Pharma Digital Technology N/A N/A N/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wellgistics Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Hong Kong Pharma Digital Technology
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Wellgistics Health has a beta of -3.14, suggesting that its share price is 414% less volatile than the broader market. Comparatively, Hong Kong Pharma Digital Technology has a beta of 2.56, suggesting that its share price is 156% more volatile than the broader market.

In the previous week, Hong Kong Pharma Digital Technology had 1 more articles in the media than Wellgistics Health. MarketBeat recorded 2 mentions for Hong Kong Pharma Digital Technology and 1 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 1.08 beat Hong Kong Pharma Digital Technology's score of 1.00 indicating that Wellgistics Health is being referred to more favorably in the media.

Company Overall Sentiment
Wellgistics Health Positive
Hong Kong Pharma Digital Technology Positive

5.7% of Wellgistics Health shares are held by institutional investors. 19.5% of Wellgistics Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Hong Kong Pharma Digital Technology has lower revenue, but higher earnings than Wellgistics Health.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellgistics Health$23.34M0.10-$101.28M-$20.41N/A
Hong Kong Pharma Digital Technology$13.43M0.08-$1.14MN/AN/A

Summary

Wellgistics Health and Hong Kong Pharma Digital Technology tied by winning 5 of the 10 factors compared between the two stocks.

How does Wellgistics Health compare to McKesson?

Wellgistics Health (NASDAQ:MEDS) and McKesson (NYSE:MCK) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.

In the previous week, McKesson had 11 more articles in the media than Wellgistics Health. MarketBeat recorded 12 mentions for McKesson and 1 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 1.08 beat McKesson's score of 0.56 indicating that Wellgistics Health is being referred to more favorably in the media.

Company Overall Sentiment
Wellgistics Health Positive
McKesson Positive

5.7% of Wellgistics Health shares are held by institutional investors. Comparatively, 85.1% of McKesson shares are held by institutional investors. 19.5% of Wellgistics Health shares are held by insiders. Comparatively, 0.1% of McKesson shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Wellgistics Health has a beta of -3.14, suggesting that its share price is 414% less volatile than the broader market. Comparatively, McKesson has a beta of 0.27, suggesting that its share price is 73% less volatile than the broader market.

McKesson has a net margin of 1.12% compared to Wellgistics Health's net margin of -564.70%. Wellgistics Health's return on equity of 0.00% beat McKesson's return on equity.

Company Net Margins Return on Equity Return on Assets
Wellgistics Health-564.70% N/A -105.00%
McKesson 1.12%-202.94%5.92%

McKesson has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than McKesson, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellgistics Health$23.34M0.10-$101.28M-$20.41N/A
McKesson$403.43B0.30$4.76B$38.8927.32

McKesson has a consensus price target of $1,054.12, suggesting a potential downside of 0.80%. Given McKesson's stronger consensus rating and higher probable upside, analysts plainly believe McKesson is more favorable than Wellgistics Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wellgistics Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
McKesson
0 Sell rating(s)
4 Hold rating(s)
15 Buy rating(s)
0 Strong Buy rating(s)
2.79

Summary

McKesson beats Wellgistics Health on 12 of the 15 factors compared between the two stocks.

How does Wellgistics Health compare to Cencora?

Wellgistics Health (NASDAQ:MEDS) and Cencora (NYSE:COR) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, institutional ownership, valuation, risk, media sentiment and profitability.

Cencora has a net margin of 1.03% compared to Wellgistics Health's net margin of -564.70%. Cencora's return on equity of 110.72% beat Wellgistics Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Wellgistics Health-564.70% N/A -105.00%
Cencora 1.03%110.72%4.22%

Cencora has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than Cencora, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Wellgistics Health$23.34M0.10-$101.28M-$20.41N/A
Cencora$337.40B0.19$3.48B$17.9219.03

5.7% of Wellgistics Health shares are held by institutional investors. Comparatively, 97.5% of Cencora shares are held by institutional investors. 19.5% of Wellgistics Health shares are held by insiders. Comparatively, 0.4% of Cencora shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, Cencora had 14 more articles in the media than Wellgistics Health. MarketBeat recorded 15 mentions for Cencora and 1 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 1.08 beat Cencora's score of 0.62 indicating that Wellgistics Health is being referred to more favorably in the media.

Company Overall Sentiment
Wellgistics Health Positive
Cencora Positive

Cencora has a consensus price target of $381.00, suggesting a potential upside of 11.71%. Given Cencora's stronger consensus rating and higher possible upside, analysts clearly believe Cencora is more favorable than Wellgistics Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Wellgistics Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Cencora
0 Sell rating(s)
3 Hold rating(s)
13 Buy rating(s)
0 Strong Buy rating(s)
2.81

Wellgistics Health has a beta of -3.14, meaning that its share price is 414% less volatile than the broader market. Comparatively, Cencora has a beta of 0.58, meaning that its share price is 42% less volatile than the broader market.

Summary

Cencora beats Wellgistics Health on 13 of the 15 factors compared between the two stocks.

How does Wellgistics Health compare to Cardinal Health?

Cardinal Health (NYSE:CAH) and Wellgistics Health (NASDAQ:MEDS) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, analyst recommendations, earnings, media sentiment, profitability, institutional ownership and dividends.

87.2% of Cardinal Health shares are held by institutional investors. Comparatively, 5.7% of Wellgistics Health shares are held by institutional investors. 0.1% of Cardinal Health shares are held by company insiders. Comparatively, 19.5% of Wellgistics Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Cardinal Health has a beta of 0.53, indicating that its stock price is 47% less volatile than the broader market. Comparatively, Wellgistics Health has a beta of -3.14, indicating that its stock price is 414% less volatile than the broader market.

Cardinal Health has a net margin of 0.71% compared to Wellgistics Health's net margin of -564.70%. Wellgistics Health's return on equity of 0.00% beat Cardinal Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Cardinal Health0.71% -102.72% 4.86%
Wellgistics Health -564.70%N/A -105.00%

Cardinal Health has higher revenue and earnings than Wellgistics Health. Wellgistics Health is trading at a lower price-to-earnings ratio than Cardinal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardinal Health$254.25B0.25$1.71B$7.7335.25
Wellgistics Health$23.34M0.10-$101.28M-$20.41N/A

Cardinal Health currently has a consensus price target of $290.13, indicating a potential upside of 6.47%. Given Cardinal Health's stronger consensus rating and higher possible upside, research analysts plainly believe Cardinal Health is more favorable than Wellgistics Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cardinal Health
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
1 Strong Buy rating(s)
2.94
Wellgistics Health
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Cardinal Health had 14 more articles in the media than Wellgistics Health. MarketBeat recorded 15 mentions for Cardinal Health and 1 mentions for Wellgistics Health. Wellgistics Health's average media sentiment score of 1.08 beat Cardinal Health's score of 0.72 indicating that Wellgistics Health is being referred to more favorably in the news media.

Company Overall Sentiment
Cardinal Health Positive
Wellgistics Health Positive

Summary

Cardinal Health beats Wellgistics Health on 13 of the 16 factors compared between the two stocks.

Get Wellgistics Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for MEDS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MEDS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MEDS vs. The Competition

MetricWellgistics HealthHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$4.29M$9.75B$7.42B$10.86B
Dividend YieldN/A2.57%2.48%4.74%
P/E Ratio-0.0732.5332.4528.84
Price / Sales0.181.938.085.38
Price / CashN/A22.1220.7221.66
Price / Book26.803.414.313.50
Net Income-$101.28M$329.93M$3.51B$394.12M
7 Day Performance80.13%-7.11%-7.89%-8.87%
1 Month Performance-51.27%-7.00%-10.43%-11.97%
1 Year Performance-94.51%13.83%-2.77%-9.56%

Wellgistics Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MEDS
Wellgistics Health
0.777 of 5 stars
$1.34
+84.1%
N/A-97.5%$4.29M$23.34MN/A31
RDGT
Ridgetech
0.0822 of 5 stars
$1.06
flat
N/A-99.8%$3.85M$132.16MN/A64
HKPD
Hong Kong Pharma Digital Technology
1.3058 of 5 stars
$1.59
-2.2%
N/A-94.3%$1.30M$13.43MN/A27
MCK
McKesson
4.034 of 5 stars
$1,103.31
+0.0%
$1,040.29
-5.7%
+24.4%$127.39B$403.43B28.3743,000
COR
Cencora
4.8347 of 5 stars
$359.12
+0.0%
$368.14
+2.5%
-5.5%$68.53B$337.40B20.0451,000

Related Companies and Tools


This page (NASDAQ:MEDS) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners